Standard
Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates. / Abtahi, Shahab; Pajouheshnia, Romin; Duran-Salinas, Carlos; Riera-Arnau, Judit; Gamba, Magdalena; Alsina, Ema; Hallgreen, Christine Erikstrup; Limoncella, Giorgio; Bartolini, Claudia; Holthuis, Emily; Martin-Perez, Mar; Brown, Jeremy; Sturkenboom, Miriam; Klungel, Olaf; Lot, Other.
In:
Drug Safety, Vol. 45, No. 10, 2022, p. 1312-1313.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Abtahi, S, Pajouheshnia, R, Duran-Salinas, C, Riera-Arnau, J, Gamba, M, Alsina, E, Hallgreen, CE, Limoncella, G, Bartolini, C, Holthuis, E, Martin-Perez, M, Brown, J, Sturkenboom, M, Klungel, O & Lot, O 2022, 'Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates', Drug Safety, vol. 45, no. 10, pp. 1312-1313.
APA
Abtahi, S., Pajouheshnia, R., Duran-Salinas, C., Riera-Arnau, J., Gamba, M., Alsina, E., Hallgreen, C. E., Limoncella, G., Bartolini, C., Holthuis, E., Martin-Perez, M., Brown, J., Sturkenboom, M., Klungel, O., & Lot, O. (2022). Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates. Drug Safety, 45(10), 1312-1313.
Vancouver
Abtahi S, Pajouheshnia R, Duran-Salinas C, Riera-Arnau J, Gamba M, Alsina E et al. Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates. Drug Safety. 2022;45(10):1312-1313.
Author
Abtahi, Shahab ; Pajouheshnia, Romin ; Duran-Salinas, Carlos ; Riera-Arnau, Judit ; Gamba, Magdalena ; Alsina, Ema ; Hallgreen, Christine Erikstrup ; Limoncella, Giorgio ; Bartolini, Claudia ; Holthuis, Emily ; Martin-Perez, Mar ; Brown, Jeremy ; Sturkenboom, Miriam ; Klungel, Olaf ; Lot, Other. / Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates. In: Drug Safety. 2022 ; Vol. 45, No. 10. pp. 1312-1313.
Bibtex
@article{6247067ca80c4b2ab65fd30a79675988,
title = "Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates",
author = "Shahab Abtahi and Romin Pajouheshnia and Carlos Duran-Salinas and Judit Riera-Arnau and Magdalena Gamba and Ema Alsina and Hallgreen, {Christine Erikstrup} and Giorgio Limoncella and Claudia Bartolini and Emily Holthuis and Mar Martin-Perez and Jeremy Brown and Miriam Sturkenboom and Olaf Klungel and Other Lot",
year = "2022",
language = "English",
volume = "45",
pages = "1312--1313",
journal = "Drug Safety",
issn = "0114-5916",
publisher = "Adis International Ltd",
number = "10",
note = "21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” ; Conference date: 20-09-2022 Through 23-09-2022",
}
RIS
TY - ABST
T1 - Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates
AU - Abtahi, Shahab
AU - Pajouheshnia, Romin
AU - Duran-Salinas, Carlos
AU - Riera-Arnau, Judit
AU - Gamba, Magdalena
AU - Alsina, Ema
AU - Hallgreen, Christine Erikstrup
AU - Limoncella, Giorgio
AU - Bartolini, Claudia
AU - Holthuis, Emily
AU - Martin-Perez, Mar
AU - Brown, Jeremy
AU - Sturkenboom, Miriam
AU - Klungel, Olaf
AU - Lot, Other
N1 - Conference code: 21
PY - 2022
Y1 - 2022
M3 - Conference abstract in journal
VL - 45
SP - 1312
EP - 1313
JO - Drug Safety
JF - Drug Safety
SN - 0114-5916
IS - 10
T2 - 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”
Y2 - 20 September 2022 through 23 September 2022
ER -
